Testicular cancer has excellent cure rates; however, poor guideline adherence can lead to inappropriate management, with a detrimental effect on outcomes. Therefore, we aimed to investigate the current patterns of care for testicular cancer patients and 
| INTRODUC TI ON
Testicular germ cell cancer (TC) is the most common cancer in young men (Robert Koch-Institut, 2016) . Within the last decade, the incidence has increased on average by 1.1% per year (Nigam, Aschebrook-Kilfoy, Shikanov, & Eggener, 2015; Ruf et al., 2014) .
TC patients differ significantly from other cancer patients due to their considerably younger age of onset (25-45 years old; mean age, 38 years), normal activity level and mobility and less overall comorbidities (Robert Koch-Institut, 2016) . Since the introduction of cisplatin-based polychemotherapy in the 1980 s, the cure rate of metastatic testicular cancer has significantly increased (Einhorn & Donohue, 1977) . Currently, more than 90% of TC patients can be cured; even in the poorest prognosis group, patients have a 5-year survival rate of approximately 48% (Albers et al., 2015) . With this increase in cure rates, attention has shifted towards decreasing treatment and diagnostic-related morbidities and improving quality of life.
For optimal staging, treatment and follow-up, it is essential to utilise current guidelines (Albers et al., 2015; Motzer et al., 2015) .
A previous study showed that non-guideline-directed care led to inappropriate imaging (44%), overtreatment (40%) and misdiagnosis (24%) (Wymer et al., 2017) . Additional studies have found insufficient post-treatment imaging rates and unnecessary adjuvant therapy regimens when compared with current guideline recommendations (Matulewicz, Oberlin, Sheinfeld, & Meeks, 2016; Rusner, Stang, Dieckmann, & Friedel, 2013) . This lack of guideline adherence can cause deteriorated outcomes.
We hypothesised that a proportion of frequently utilised TC diagnostic and treatment regimens may not be in line with current guideline recommendations; thus, the aim of the present study was to investigate patterns of care for testicular cancer patients and to evaluate guideline adherence amongst German urologists.
| ME THODS

| Study design
We designed a 19-item survey to assess guideline adherence and patterns of care for TC patients among German urologists between September 2015 and September 2016. The applied German questionnaire and an English translation can be found in the Supporting Information. All members of our working group developed and piloted this survey. Throughout this process, we modified the wording to improve understanding. Fifteen volunteers tested the survey, and it showed good face validity. Finally, this anonymous questionnaire was distributed at 12 advanced training courses and regional meetings.
The questionnaire consisted of five domains: baseline characteristics, initial staging (cryopreservation, biopsy of the contralateral testis, timing of the imaging studies, applied imaging modalities and the evaluation of these studies), follow-up examination (applied imaging modalities, use of abdominal magnetic resonance imaging (MRI) and regular work-up during follow-up visits), general issues (guidelines used, whether a second opinion should be offered in metastatic TC, and whether minimal caseload requirements were necessary) and a practical question concerning the follow-up algorithm for Stage I seminoma under active surveillance. The intention of this practical question was to assess whether guidelines are implemented in the daily routine (Vossen, Horwich, Daugaard, van Poppel, & Osanto, 2012) .
Responses were analysed based on adherence to grade "A" recommendations from the 2015 European Association of Urology (EAU) guidelines (Albers et al., 2015 
| Analyses
Questionnaires with at least nine completely answered items were included in the present study. Values are expressed as the mean ± standard deviation and range. We report absolute and relative frequencies and applied the chi-square test for group comparison.
Statistical calculations were performed using the Statistical Package for the Social Sciences v24 software (SPSS Inc., Chicago, IL, USA). A p-value of <0.05 is considered statistically significant.
German urologists (n = 6,504) and residents (n = 1,210 a ) 
| RE SULTS
| Survey responses
The questionnaire was distributed to a total of 920 German urologists. The initial response rate was 59% (n = 543). After excluding incomplete questionnaires, n = 411 (45%) questionnaires fulfilled the requirements for further analysis.
| Baseline characteristics
We compared sociodemographic data with the official statistics of registered physicians of the Federal Medical Council ( 
| General topics
The most frequently used guideline for the management of TC patients was the EAU guideline in 62.2% (n = 230), followed by national guidelines (30.8%; n = 114), European Consensus Conference on diagnosis and treatment of germ cell cancer by the European Germ
Cell Cancer Consensus Group (EGCCCG) (22.7%; n = 84), standard operating procedures of the individual hospital (11.9%; n = 44) and the American guidelines (National Comprehensive Cancer Network
[NCCN]) (7.6%; n = 28) (Albers et al., 2015; Krege et al., 2008; Motzer et al., 2015) .
A routine second opinion for metastatic TC was supported by 76.9% (n = 247), while not being supported by 15.3% (n = 49).
Physicians treating fewer patients supported a standard second opinion more frequently (≤5 TC/year: 88.2% vs. >31 TC/year: 46.7%,
Minimum caseload requirements for treating metastatic TC were rejected by 35.8% (n = 114), but advocated for by 47.7% (n = 152). A minimum annual caseload of ≥10 was advocated by 20.4%, of ≥25 by 17.9% and of ≥50 by 9.4%, while 16.4% (n = 52) had no opinion.
Minimal case numbers were significantly more often rejected in the outpatient sector and by non-academic hospitals as compared with university hospitals (47.4% vs. 14.3%, p < 0.001). However, the number of treated TC patients per year had no significant impact on the attitude regarding caseload minimums.
| Initial staging
Of the survey participants, 19.2% did not typically recommend cryopreservation prior to orchiectomy, and 63.1% regularly performed a contralateral testicular biopsy (Table 2) . Initial imaging was performed prior to orchiectomy in 25.1% (n = 88) or following orchiectomy in 49.7% (n = 174), while 25.1% (n = 88) reported no standard procedure.
Patterns of care for initial staging examinations of TC patients are provided in Table 3 . Chest X-ray was more often used by office urologists than hospital-based clinicians (21.9% vs. 8.9%, p = 0.022) and by physicians treating ≤15 TC patients per year as compared with those treating >15 cases (23.8% vs. 6.0%, p = 0.011).
The imaging used for initial staging was typically reviewed by written reports in 55.0% (n = 181), during a radiological conference in 38.6% (n = 127) or by the urologists themselves in 4.9% (n = 16).
Written reports alone were used more frequently by office urologists as compared with hospital-based clinicians (69.6% vs. 28.4%, p < 0.001) and by specialists as compared with residents (65.1% vs.
21.1%, p < 0.001). Interdisciplinary conferences were more common in hospitals as compared with office urologists (63.2% vs. 24.5%, p < 0.001) and for residents as compared with specialists (69.0% vs.
29.7%, p < 0.001).
| Follow-up care
Information on follow-up imaging is provided in Table 3 . In 65.3%
(n = 248), the same imaging modality was used as that in the initial staging.
MRI of the abdomen was used more frequently in younger patients (43.9%; n = 164) and in the cases of allergy to contrast media or renal insufficiency (46.0%; n = 172). Only 14.2% (n = 53) always used MRI for abdominal imaging, and MRI was not sufficiently available to 3.5% (n = 13). Similar to the initial imaging modality, MRI for follow-up care was more often used by office urologists than by hospital-based urologists (19.0% vs. 5.4%, p = 0.014) and by urologists with work experience of >5 years (17.2% vs. 5.9%, p = 0.041).
The following outcomes were monitored during follow-up care: follow-up by 90% (n = 279), while 8.7% (n = 27) only checked the markers that were initially elevated, and 1.3% did not check any markers (n = 4) ( 
| Practical question concerning active surveillance for Stage I seminoma
The suggested active surveillance protocol for Stage I seminoma is shown in Table 4 . Correct follow-up diagnostics according to the EAU guidelines were mostly stated by young specialists (≤5 years: 
| D ISCUSS I ON
We surveyed German urologists concerning guideline adherence and patterns of care for TC patients, with an effective response rate of 45%. Since most of the participants used the EAU guidelines According to the EAU guidelines, cryopreservation should be discussed with all men prior to orchiectomy to preserve fertility. This is extremely important, since up to 77% of TC survivors have an interest in paternity (Dohle, 2010) and the semen quality is significantly lower following orchiectomy (Rives et al., 2012 ). An explanation may be that even cancer-baring testis has a spermatogenesis up to 62% (Choy et al., 2013) . However, 20% of the survey participants did not regularly offer this option. The possibility of cryopreservation should be offered to every TC patient without deviation.
A total of 63.1% of the survey participants regularly performed a contralateral testicular biopsy; this practice pattern does not match the EAU guidelines and causes unnecessary trauma. According to the EAU guidelines, it should be offered to patients at high risk of intratubular germ cell neoplasia of the testis (ITGCN) (testicular volume <12 ml, a history of cryptorchidism or poor spermatogenesis), but not in patients older than 40 years who lack risk factors (Albers et al., 2015) . Germany is one of the countries in which the routine use of contralateral biopsy is relatively common (Ruf et al., 2015) . We should break away from the old tradition and apply risk stratification according to guideline recommendations to detect the maximum number of ITGCN cases, but also to reduce unnecessary iatrogenic trauma.
For initial staging, chest CT and abdominal CT were correctly utilised by >80% of urologists. Our guideline compliance rates were significantly improved as compared with a previous study that retrospectively analysed 593 TC patients and found an inappropriate imaging rate of 44% with respect to the NCCN guidelines (Wymer et al., 2017) . A French survey of 289 urologists revealed a guideline adherence rate of 66% for the initial radiological workup (Rigaud et al., 2014) . Reasons for the occasional use of X-ray may be faster screening for progressive disease, as recommended by NCCN (Motzer et al., 2015) . Furthermore, X-ray was significantly more often used by physicians treating <15 TC patients per year. The positive impact of higher caseloads has been demonstrated for other indications such as radical prostatectomy (Groeben, Koch, Baunacke, Wirth, & Huber, 2017) . A minimum caseload may be defined for treating metastatic TC, as advocated by almost half of the participants.
For a real-life impression concerning follow-up, we asked for the active surveillance algorithm in Stage I seminoma. We found that only approximately half of the participants adhered to or could remember the recommendations. Correct follow-up diagnostics according to the EAU guidelines were significantly more often applied by younger specialists. Since relapse in Stage I seminoma occurs most frequently within the first two years, CTs after 4 years are only rarely indicated (Nayan et al., 2017) . Only one study evaluated the frequency of CT imaging during the follow-up of TC patients and identified 177 patients who received a mean of 4.4 CT scans, although 6.2 scans would have been expected based on former guidelines (Rusner et al., 2013) . Our present data show roughly equal overuse and underuse of CT imaging; this difference could be due to our larger study population and less recommended follow-up CTs according to current guidelines. The double-edged sword of followup imaging weighs the possibility of missing a recurrence if used too infrequently against excessive and unnecessary radiation exposure if used too frequently (Curreri, Fung, & Beard, 2015) . Each CT scan bears the potential to lead to cellular damage, and in turn, a secondary cancer. This risk is increased particularly in younger patients and those undergoing repeated examinations with an increased cumulative risk (Brenner & Hall, 2007) . Estimates assume that a single CT of the abdomen induces one case of secondary cancer in every 660 patients (Smith-Bindman et al., 2009) ; thus, strict adherence to the follow-up recommendations reduces unnecessary radiation.
Since younger specialists tended to apply the follow-up much better (≤5 years: 33.3% vs. >5 years: 16.7%, p = 0.032), further educational means appear to be necessary, in particular, continued education programmes may deserve more attention.
To reduce radiation burden, MRI is an acceptable alternative to CT and is comparably reliable in experienced hands (Sohaib et al., 2009 ). However, the results of a randomised phase III trial comparing MRI and CT scan schedules in patients with Stage I seminoma are still awaited (NCT00589537). According to the EAU guidelines, abdominal MRI is a suitable imaging modality and has been approved for several situations (Albers et al., 2015; Mosavi, Laurell, & Ahlstrom, 2015; Sohaib et al., 2009) . Based on our survey findings, MRI is widely available in Germany; therefore, it is a valid option for radiation-free follow-up imaging of the abdomen if performed by experienced radiologists.
Consistent clinical follow-up of TC patients must also observe possible therapy-related (late) side effects, including cardiovascular disease, metabolic syndrome, hypogonadism, and secondary tumours (Einhorn et al., 2016; Fung, Fossa, Milano, Oldenburg, & Travis, 2013; Haugnes, Oldenburg, & Bremnes, 2015; Willemse et al., 2013) . Patients treated with chemotherapy or radiotherapy have a considerably increased risk of secondary tumours and cardiovascular events. Moreover, psychological disorders may be underestimated long-term sequelae in TC survivors (Dahl et al., 2016; Sprauten et al., 2015) . Based on the present findings, these aspects are largely underrepresented among German urologists, and there is a huge need for optimisation. Great effort should be made to raise urologists' awareness concerning late side effects that must be investigated continuously during follow-up. Furthermore, patients should be educated regarding the possible long-term consequences at the time of treatment.
| Strengths and limitations
We conducted the largest survey to date among urologists concerning the practice patterns of diagnosis and follow-up of TC patients. Our response rate was higher as compared with a French survey of 289 urologists (45% vs. 29%) (Rigaud et al., 2014) .
Although our findings are not representative of all German urologists due to non-responder bias and recruitment mode, we found a sufficient match of sociodemographic data, with office urologists and residents being slightly overrepresented. Therefore, our results provide a realistic impression of the actual practice patterns in Germany and are reliable for explorative and hypotheses-generating questions. We were unable to control for the effect of social desirability, but this should be of minor importance using an anonymous questionnaire.
| CON CLUS ION
German urologists showed relatively strong guideline adherence, especially concerning the initial staging; however, some areas should be improved. Cryopreservation should be offered to every TC patient without deviation. Contralateral biopsy should be used following risk adaptation, according to the guidelines. For the scheduling of follow-up, we should use the guideline tables, since recalling the active surveillance protocol showed insufficient results. Since MRI is widely available, efforts should be made to use it more frequently, particularly for follow-up imaging, in order to reduce the radiation burden for the young TC patients. Clinical follow-up is important for the detection of long-term side effects and late toxicities, including cardiovascular disease, metabolic syndrome, hypogonadism and secondary tumours.
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